Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Herbalife sales increase, president resigns

This article was originally published in The Tan Sheet

Executive Summary

Herbalife's first-quarter net sales increased 19 percent to $604.4 million, the firm announced May 1. The Los Angeles-based firm says the "record performance" was attributable to double-digit growth in several of is top markets, including the U.S. (14.3 percent), Taiwan (14.8 percent), Italy (29.7 percent), China (111.5 percent), Japan (10.4 percent) and Spain (30.2 percent). In April, Spain health authorities cautioned against Herbalife products citing hepatic toxicity (1"The Tan Sheet" April 28, 2008, In Brief). In addition, President and Chief Operating Officer Gregory L. Probert resigned April 30. Herbalife says the board of directors had no choice but to accept the resignation after reviewing misstatements of Probert's academic credentials. Other Herbalife personnel assumed Probert's responsibilities and Des Walsh, senior VP of worldwide sales, was promoted to executive VP...

Related Content

Topics

UsernamePublicRestriction

Register

PS101617

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel